These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33135946)

  • 1. Predictors of participation restriction over a 9-year period in adults with myotonic dystrophy type 1.
    Raymond K; Levasseur M; Gallais B; Richer L; Laberge L; Petitclerc É; Mathieu J; Gagnon C
    Disabil Rehabil; 2022 Jun; 44(12):2615-2631. PubMed ID: 33135946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive Decline in Daily and Social Activities: A 9-year Longitudinal Study of Participation in Myotonic Dystrophy Type 1.
    Raymond K; Levasseur M; Mathieu J; Gagnon C
    Arch Phys Med Rehabil; 2019 Sep; 100(9):1629-1639. PubMed ID: 30831092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing upper extremity capacity as a potential indicator of needs related to household activities for rehabilitation services in people with myotonic dystrophy type 1.
    Raymond K; Auger LP; Cormier MF; Vachon C; St-Onge S; Mathieu J; Noreau L; Gagnon C
    Neuromuscul Disord; 2015 Jun; 25(6):522-9. PubMed ID: 25953319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of disrupted social participation in myotonic dystrophy type 1.
    Gagnon C; Mathieu J; Jean S; Laberge L; Perron M; Veillette S; Richer L; Noreau L
    Arch Phys Med Rehabil; 2008 Jul; 89(7):1246-55. PubMed ID: 18586127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hand-training in persons with myotonic dystrophy type 1--a randomised controlled cross-over pilot study.
    Aldehag A; Jonsson H; Lindblad J; Kottorp A; Ansved T; Kierkegaard M
    Disabil Rehabil; 2013 Oct; 35(21):1798-807. PubMed ID: 23480644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial.
    Okkersen K; Jimenez-Moreno C; Wenninger S; Daidj F; Glennon J; Cumming S; Littleford R; Monckton DG; Lochmüller H; Catt M; Faber CG; Hapca A; Donnan PT; Gorman G; Bassez G; Schoser B; Knoop H; Treweek S; van Engelen BGM;
    Lancet Neurol; 2018 Aug; 17(8):671-680. PubMed ID: 29934199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple Case Study of Changes in Participation of Adults with Myotonic Dystrophy Type 1: Importance of Redesigning Accomplishment and Resilience.
    Raymond K; Gagnon C; Levasseur M
    J Neuromuscul Dis; 2022; 9(6):731-755. PubMed ID: 36214003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participation and the Role of Neuropsychological Functioning in Myotonic Dystrophy Type 1.
    Van Heugten C; Meuleman S; Hellebrekers D; Kruitwagen-van Reenen E; Visser-Meily J
    J Neuromuscul Dis; 2018; 5(2):205-214. PubMed ID: 29865086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective study of needs and interventions among patients with myotonic dystrophy type 1 in Denmark referred to rehabilitation in the period 2000-2019.
    Allergodt K; Handberg C; Frost A; Werlauff U
    J Eval Clin Pract; 2023 Feb; 29(1):39-48. PubMed ID: 35615973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consensus-Based Care Recommendations for Pulmonologists Treating Adults with Myotonic Dystrophy Type 1.
    Boentert M; Cao M; Mass D; De Mattia E; Falcier E; Goncalves M; Holland V; Katz SL; Orlikowski D; Sannicolò G; Wijkstra P; Hellerstein L; Sansone VA
    Respiration; 2020; 99(4):360-368. PubMed ID: 32299079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overground exoskeletons may boost neuroplasticity in myotonic dystrophy type 1 rehabilitation: A case report.
    Portaro S; Naro A; Leo A; Cimino V; Balletta T; Buda A; Accorinti M; Calabrò RS
    Medicine (Baltimore); 2019 Nov; 98(46):e17582. PubMed ID: 31725606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive behaviour therapy plus aerobic exercise training to increase activity in patients with myotonic dystrophy type 1 (DM1) compared to usual care (OPTIMISTIC): study protocol for randomised controlled trial.
    van Engelen B;
    Trials; 2015 May; 16():224. PubMed ID: 26002596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncovering health and social care needs among myotonic dystrophy patients: Utility of the Needs and Provisions Complexity Scale.
    Holmøy AKT; Johannessen CH; Hope S; van Walsem MR; Aanonsen NO; Hassel B
    Acta Neurol Scand; 2019 Jun; 139(6):526-532. PubMed ID: 30848487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of muscular strength and functional capacity in the juvenile and adult myotonic dystrophy type 1 population: a 3-year follow-up study.
    Roussel MP; Fiset MM; Gauthier L; Lavoie C; McNicoll É; Pouliot L; Gagnon C; Duchesne E
    J Neurol; 2021 Nov; 268(11):4221-4237. PubMed ID: 33907889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rehabilitation interventions for foot drop in neuromuscular disease.
    Sackley C; Disler PB; Turner-Stokes L; Wade DT; Brittle N; Hoppitt T
    Cochrane Database Syst Rev; 2009 Jul; (3):CD003908. PubMed ID: 19588347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 9-year follow-up study of the natural progression of upper limb performance in myotonic dystrophy type 1: A similar decline for phenotypes but not for gender.
    Raymond K; Levasseur M; Mathieu J; Desrosiers J; Gagnon C
    Neuromuscul Disord; 2017 Jul; 27(7):673-682. PubMed ID: 28527585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of participation in myotonic dystrophy: reliability of the LIFE-H.
    Gagnon C; Mathieu J; Noreau L
    Neuromuscul Disord; 2006 Apr; 16(4):262-8. PubMed ID: 16545567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved grip myotonia in a patient with myotonic dystrophy type 1 following electroacupuncture therapy: A CARE-compliant case report.
    Yoon SH; Baek JH; Leem J
    Medicine (Baltimore); 2020 Sep; 99(37):e21845. PubMed ID: 32925721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation restriction in childhood phenotype of myotonic dystrophy type 1: a systematic retrospective chart review.
    Gagnon C; Kierkegaard M; Blackburn C; Chrestian N; Lavoie M; Bouchard MF; Mathieu J
    Dev Med Child Neurol; 2017 Mar; 59(3):291-296. PubMed ID: 27671786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 9-year follow-up study of quantitative muscle strength changes in myotonic dystrophy type 1.
    Gagnon C; Petitclerc É; Kierkegaard M; Mathieu J; Duchesne É; Hébert LJ
    J Neurol; 2018 Jul; 265(7):1698-1705. PubMed ID: 29785524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.